Pashna Munshi, MD | Authors

Articles

Ruxolitinib Adverse Event Data and Strategies for Managing Side Effects

April 07, 2022

Pashna Munshi, MD, provides an overview of adverse event data from the REACH3 trial of ruxolitinib in patients with steroid-refractory cGVHD and discusses management of patients’ side effects in clinical practice.